Roquefort Therapeutics plc (LON:ROQ)
London
· Delayed Price · Currency is GBP · Price in GBX 1.500
+0.045 (2.99%)
May 16, 2025, 4:35 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 2.32 million as of May 16, 2025. Its market cap has decreased by -59.09% in one year.
Market Cap
2.32M
Enterprise Value
2.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 2.32M, an increase of 6.29%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 2.32M | -57.71% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.18B |
| GSK plc | 56.63B |
| Haleon | 36.40B |
| Smith & Nephew | 9.50B |
| ConvaTec Group | 5.57B |
| Hikma Pharmaceuticals | 4.56B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.38B |